Categories
Health Care Law & Regulation Manufacturing Politics & Society

China to reduce drug prices

New government-instituted price ceilings for cancer, immune and blood-system drugs in China will bring costs down by an average of 17%, The Wall Street Journal reported, citing information posted online by a government agency. The price cuts on 95 oncology, immune-system and blood-related drugs, as well as 200 formulations, will be implemented on October 8. […]

Categories
Health Care Law & Regulation

Chinese authorities detain 2,000 in counterfeit drug crackdown

Chinese authorities seized more than US$182 million worth of counterfeit pharmaceuticals and detained nearly 2,000 suspects involved in their distribution last month, The Wall Street Journal reported, citing a statement by China’s public security minister issued on Sunday. The counterfeit pharmaceuticals included drugs usually prescribed for patients with diabetes, high blood pressure and rabies, and […]

Categories
Business Health Care Investment Markets

Grey-haired tsunami

Beijing prepares for a looming pension crisis

Categories
Health Care Investment

Eli Lilly invests $20m in Chinese general drug maker

Eli Lilly (LLY.NYSE) invested an additional US$20 million in Chinese drug maker Novast Laboratories as it seeks a stronger foothold in China’s generic medicines market, The Wall Street Journal reported. Novast plans to use the funding to increase its manufacturing capacity of generic drugs at its Jiangsu site over the next few years. Eli Lilly […]

Categories
Health Care

Chinese scientist found guilty of stealing Merck drugs

A Chinese researcher at WuXi PharmaTech (WX.NYSE) was found guilty in a Shanghai court of stealing and selling patented medical compounds from US pharmaceutical giant Merck & Co (MRK.NYSE), The Wall Street Journal reported. The Shanghai Pudong New Area People’s Court ruled on May 16 that a defendant it identified only as Mr Wang had […]